Concepedia

Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission

Sarah H. Wild, Jeremy Walker, Joanne R Morling, David McAllister, Helen M. Colhoun, Bassam Farran, Stuart J. McGurnaghan, Rory J. McCrimmon, Stephanie H. Read, Naveed Sattar,

Diabetes Care · 2017 · 140 citations · 22 references

DOIFull text

Open access

Abstract

Hospital records of ALD or NAFLD are associated to varying degrees with an increased risk of CVD, cancer, and mortality among people with T2DM.

References

22

An Approximate Distribution of Estimates of Variance Components

F. E. Satterthwaite · Biometrics Bulletin · 1946 · 4.3K citations

, , +5

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

Matthew J. Armstrong, Piers Gaunt, Guruprasad P. Aithal et al. · The Lancet · 2015 · 2K citations · Full text

, , +5

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management

Stuart McPherson, Timothy Hardy, Elsbeth Henderson et al. · Journal of Hepatology · 2014 · 1K citations · Full text

Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients

Giovanni Targher, Lorenzo Bertolini, Roberto Padovani et al. · Diabetes Care · 2007 · 985 citations · Full text

Excess Mortality among Persons with Type 2 Diabetes

Mauro Tancredi, Annika Rosengren, Ann‐Marie Svensson et al. · New England Journal of Medicine · 2015 · 966 citations · Full text